Standard BioTools's total assets for Q3 2025 were $539.64M, a decrease of -3.11% from the previous quarter. LAB total liabilities were $139.98M for the fiscal quarter, a 5.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.